Tenet Healthcare Corp. (THC) Posts Q2 Loss of 27c/Share; Boosts FY14 adj.-EBITDA Outlook

Go back to Tenet Healthcare Corp. (THC) Posts Q2 Loss of 27c/Share; Boosts FY14 adj.-EBITDA Outlook

Raymond James Upgrades Tenet Healthcare (THC) to Outperform

August 6, 2014 7:26 AM EDT

Raymond James upgraded Tenet Healthcare (NYSE: THC) from Market Perform to Outperform with a price target of $65.00.

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $54.83 yesterday.

... More

Susquehanna Upgrades Tenet Healthcare (THC) to Neutral

August 5, 2014 6:54 AM EDT

Susquehanna upgraded Tenet Healthcare (NYSE: THC) from Negative to Neutral.

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $53.30 yesterday.

... More